NARI Inari Medical

Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference

Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference

IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcoming Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024, at 11:20 AM Pacific Time.

A live audio webcast and replay of the presentation may be accessed for 30 days on the “Investor Relations” section of the company’s website at

About Inari Medical, Inc.

Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous disease, including venous thromboembolism, chronic venous disease and beyond. We are just getting started. Learn more at and connect with us on , , and .

Investor Contact:

John Hsu, CFA

VP, Investor Relations

949-658-3889



EN
06/05/2024

Underlying

NARIInari Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inari Medical

 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical to Participate in the 2024 Bank of America Securities He...

Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference IRVINE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today its management team will present at the upcoming Bank of America Securities Healthcare Conference on Wednesday, May 15, 2024, at 11:20 AM Pacific Time. A live audio webcast and replay of the presentation may be accessed for 30 days on the “Investor Relations” sectio...

May 6, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Reports First Quarter 2024 Financial Results

Inari Medical Reports First Quarter 2024 Financial Results IRVINE, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended March 31, 2024. First Quarter Financial and Recent Business Highlights Generated revenue of $143.2 million in Q1 of 2024, up 23.3% over the same quarter last year.GAAP operating loss was $17.2 million in Q1 of 2024, compared to a $5.3 million operat...

April 30, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical to Announce First Quarter 2024 Financial Results

Inari Medical to Announce First Quarter 2024 Financial Results IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. Interested par...

April 17, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Announces the Release of 2023 Ethos and Sustainability R...

Inari Medical Announces the Release of 2023 Ethos and Sustainability Report IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2023 Ethos and Sustainability Report. The report highlights Inari’s commitment to its ethos and important corresponding environmental, social and governance (ESG) initiatives. The report can be found on Inari’s website “We are proud to issue our third an...

April 11, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Strengthens Senior Leadership Team with Addition of Two ...

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice President of Medical Affairs. Mr. Benner will be responsible for developing effective strategies across the company's multi-product sales platform and leading a high-performance commercial team to drive therapy penetration. Dr. Niekamp will be instrumental in advancing Inari’s mission to improve pati...

April 2, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch